News FDA probes blood cancer immunotherapy safety Regulator reviewing combination therapy safety after issue with Keytruda
News AZ tried to buy Daiichi Sankyo last year - report Trading in shares of Daiichi Sankyo was suspended yesterday.
News AZ to develop Parkinson's drug with Takeda AstraZeneca could receive up to $400 million from Takeda after approaching the company to jointly develop and market a new treatment for Parkinson’s disease (PD).
News Samsung Bioepis signs R&D agreement with Takeda South Korean firm looking to develop novel drugs
News Novo's semaglutide outperforms Lilly GLP-1 rival If approved semaglutide could become set the standard for GLP-1 therapy
R&D Sponsored Turning recruitment potential into enrolment reality In the fourth episode of the IQVIA-sponsored PSCS leadership video series, Karen Townsend, senior director of medical affairs discusses SEELs
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
